Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TrueBlue (TBI) EBITDA (2016 - 2025)

Historic EBITDA for TrueBlue (TBI) over the last 17 years, with Q3 2025 value amounting to -$2.1 million.

  • TrueBlue's EBITDA rose 7032.51% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.8 million, marking a year-over-year increase of 7420.87%. This contributed to the annual value of -$127.2 million for FY2024, which is 75578.13% down from last year.
  • According to the latest figures from Q3 2025, TrueBlue's EBITDA is -$2.1 million, which was up 7032.51% from $475000.0 recorded in Q2 2025.
  • TrueBlue's 5-year EBITDA high stood at $22.3 million for Q2 2022, and its period low was -$104.5 million during Q2 2024.
  • For the 5-year period, TrueBlue's EBITDA averaged around -$2.1 million, with its median value being -$1.3 million (2023).
  • In the last 5 years, TrueBlue's EBITDA surged by 36158.15% in 2021 and then plummeted by 143277.1% in 2024.
  • TrueBlue's EBITDA (Quarter) stood at $20.1 million in 2021, then crashed by 63.06% to $7.4 million in 2022, then plummeted by 129.54% to -$2.2 million in 2023, then plummeted by 528.64% to -$13.8 million in 2024, then surged by 84.51% to -$2.1 million in 2025.
  • Its EBITDA was -$2.1 million in Q3 2025, compared to $475000.0 in Q2 2025 and -$14.4 million in Q1 2025.